Skip to main content

Metastasis From Malignant Tumor of Prostate clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

    open to eligible males ages 18 years and up

    A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.

    San Francisco, California and other locations

Last updated: